Cutting-Edge Technology Optimizes Cancer Therapy with Nanomedicine Drug Combinations
February 26, 2015
(Nanotechnology Now) – In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy. And one of their greatest challenges is determining which ratio and combination — from the large number of medications available — is best for each individual patient.